Vitasora Health (VHL) Q1 2026 TU earnings summary

Executive summary

• Patient programs grew to 22,458, up 7.6% quarter-on-quarter and over 8x year-over-year, despite losing 1,000 programs from a legacy client contract.

• Expansion of Medicaid and fee-for-service (FFS) programs, including new contracts with Tampa Family Health Centers and Iris Medical Group, is expected to drive further revenue growth.

• Enhanced enrolment and engagement frameworks, supported by AI-driven automation, improved scalability and conversion rates, especially in the West Virginia program.

Financial highlights

• Quarterly revenue reached A$1.07 million, a 160% year-over-year increase, maintaining above A$1 million for consecutive quarters.

• Cash receipts from customers totaled A$1.43 million, with A$1.1 million in receivables expected post-quarter.

• Operating cash outflows were A$3.37 million, up 43% quarter-on-quarter, mainly due to timing of prior period settlements and scaling activities.

• Underlying P&L expenses for the quarter were A$3.5 million, down 12% from the previous quarter.

• Integration synergies from Orb Health generated savings of approximately US$146K (A$233K) per month.

Outlook and guidance

• New and expanded FFS programs are expected to drive significant revenue growth in the December quarter.

• Fully funded through to forecast cash-flow breakeven by Q4 FY2026, with additional flexibility for U.S. commercial expansion.

• Anticipated acceleration in onboarding and billing cycles across new contracts.